Single agents known to be active in head and neck cancer

S. Monfardini, A. Volonterio, S. Marchini

Research output: Contribution to journalArticlepeer-review


Despite good results of polychemotherapy in head and neck cancer, monochemotherapy retains a valuable role in managing patients with advanced disease. In a palliative setting, lower toxicity and simpler handling of therapy with single agents are outlined by the Authors, who review results of most active drugs in their different schedules.

Original languageEnglish
Pages (from-to)303-309
Number of pages7
Issue number4
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)


Dive into the research topics of 'Single agents known to be active in head and neck cancer'. Together they form a unique fingerprint.

Cite this